Genetic lesions in a preleukemic aplasia phase in a child with acute lymphoblastic leukemia
β Scribed by Sharon W. Horsley; Susan Colman; Mark McKinley; Caroline M. Bateman; Meriel Jenney; Tracy Chaplin; Bryan D. Young; Mel Greaves; Lyndal Kearney
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 337 KB
- Volume
- 47
- Category
- Article
- ISSN
- 1045-2257
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
In a small fraction (βΌ2%) of cases of childhood acute lymphoblastic leukemia (ALL) clinical presentation of leukemia is preceded, some 2β9 months earlier, by a transient, remitting phase of nonclassical aplastic anemia, usually in connection with infection. The potential βpreleukemicβ nature of this prodromal phase has not been fully explored. We have retrospectively analyzed the blood and bone marrow of a child who presented with aplastic anemia 9 months before the development of ETV6βRUNX1 fusion gene positive ALL. High resolution SNP genotyping arrays identified 11 regions of loss of heterozygosity, with and without concurrent copy number changes, at the presentation of ALL. In all cases of copy number change, the deletion or gain identified by single nucleotide polymorphism (SNP) analysis was confirmed in the ALL blasts by FISH. Retrospective analysis of aplastic phase bone marrow showed that the ETV6βRUNX1 fusion was present along with all of the additional genetic changes assessed, albeit subclonal to ETV6βRUNX1. These data identify for the first time the leukemic genotype of an aplasia preceding clinical ALL and indicate that multiple secondary genetic abnormalities can contribute to a dominant subclone several months before a diagnosis of ALL. These data have implications for the biology of ALL and for management of similar patients. Β© 2008 WileyβLiss, Inc.
π SIMILAR VOLUMES
Monosomy 21 and metacentric markers corresponding in size to chromosomes 8 to 12 were found as the only clonal chromosomal changes in a child with acute lymphoblastic leukemia (ALL). Chromosome painting with a whole chromosome 2 I -specific probe showed that the marker originated from chromosome 2 I